BIOVIC B — Biovica International AB Share News
0.000.00%
Last trade - 00:00- SEK88.74m
- SEK43.18m
- SEK13.38m
Brief: Biovica International Signs Agreement With Eurobio Scientific
Brief: Biovica Signs Order For TKA Test Services
Brief: Biovica International Q2 Sales SEK 2.312 Million
Brief: Biovica Signs Agreement With American Health Giant
Brief: Biovica Signs Agreement With UK Biotech Company
Brief: Biovica Announces Outcome Of Exercise Of Warrants Of Series To 3 B
Brief: Biovica Signs Order Worth SEK 2.2 Mln
Brief: Biovica Signs Agreement With US Biotech Company
Brief: Biovica International Q1 Sales SEK 1.714 Million
Brief: Biovica Carries Out Directed Issue Of Units Of Approx. Sek 16.4 Million
Brief: Biovica International Gets Work Order From US Biopharma Co
Brief: Biovica International Q4 Sales SEK 1.899 Million
Brief: Biovica Announces Cost Reduction Program In Sweden And US
Brief: Biovica International Says Observational Trial With Divitum TKa Started
Brief: Biovica Gets Positive Patent Notification For Immunotherapies
Brief: Biovica International Q3 Sales SEK 1.075 Million
Brief: Biovica Signs Contract With Biopharmaceutical Company With First Order Of SEK 1.2 Mln
Brief: Biovica Signs Master Service Agreement For TKa Testing, With First Order Of SEK 1.7 Mln
Brief: Biovica Signs Agreement With Palex Group